ARTICLES LIST

 

Total Results: 16203

Media ID Source Name Media Type Language Media Name Media Description Keywords Keywords Link to Article
1425 National Cancer Institute Html en Ewing Sarcoma Treatment (PDQ®)–Health Professional Version Expert-reviewed information summary about the treatment of Ewing sarcoma.
ewing sarcoma0.955451
Localized Ewing Sarcoma0.516622
standard-risk Ewing sarcoma0.50921
localized ewing tumors0.458678
pelvic ewing sarcoma0.53548
non-metastatic ewing0.447666
Ewing family tumors0.476484
Cooperative Ewing Sarcoma0.57252
Primary Ewing tumor0.442949
genetically confirmed Ewing0.443739
recurrent Ewing sarcoma0.50281
high-risk Ewing sarcoma0.510965
soft tissue ewing0.474262
Ewing sarcoma regimen0.517079
Sarcoma Studies patients0.436849
sarcoma treatment0.437736
ewing sarcoma family0.677203
Ewing sarcoma patients0.582131
Ewing tumor patients0.46609
Ewing Sarcoma Study0.512708
radiation therapy0.475396
Cutaneous Ewing sarcoma0.543452
Ewing sarcoma trials0.520061
extraosseous Ewing sarcoma.0.438839
et al.0.575718
extraskeletal Ewing sarcoma0.55299
tissue Ewing sarcoma0.517715
sarcoma family tumors0.500986
Ewing sarcoma molecularly.0.525686
nonmetastatic Ewing sarcoma0.582468
secondary Ewing sarcoma0.532715
PUBMED Abstract0.436153
extraosseus Ewing tumors0.450361
extraosseous ewing sarcoma0.608612
Pediatr Blood Cancer0.643087
prognosis Ewing family0.435199
Intergroup Cooperative Ewing0.452427
advanced Ewing tumors0.44875
nonmetastatic extraosseous Ewing0.439621
subcutaneous Ewing sarcoma0.543232
Ewing sarcoma.0.468942
primary Ewing sarcoma0.527784
Abstract0.588175
Clin Oncol0.669349
multifocal Ewing sarcoma0.559473
metastatic Ewing tumors0.450872
Ewing tumor0.52176
ewing tumors0.573464
non metastatic Ewing0.435213
CLICK HERE
1493 National Cancer Institute Html en Oropharyngeal Cancer Treatment (PDQ®)–Health Professional Version Expert-reviewed information summary about the treatment of oropharyngeal cancer.
neck radiotherapy0.359364
locally advanced head0.471621
Engl J Med0.53665
American Cancer Society0.443811
well-lateralized oropharyngeal cancer0.401103
neck radiation therapy0.384516
Int J Radiat0.508851
neck cancer patients0.486158
squamous cell cancer0.411067
Radiat Oncol Biol0.753309
DeVita VT Jr0.383261
Natl Cancer Inst0.447951
neck cancers0.433823
Clin Cancer Res0.390283
radiation therapy0.610067
human papillomavirus0.44587
smoking-related oropharyngeal cancer0.443579
HPV-positive oropharyngeal cancer0.448716
et al.0.570118
Mendenhall WM0.369324
Cancer Genet Cytogenet0.359903
Head Neck0.484421
index nonoropharyngeal cancer0.350094
Oropharyngeal tumors0.352557
index oropharyngeal SCC0.386084
neck SCC0.359598
oropharyngeal cancers0.476599
HPV-positive oropharyngeal cancers0.469127
anterior tonsillar pillar0.378606
Cancer Epidemiol Biomarkers0.378376
neck squamous cell0.377126
head0.534685
PUBMED Abstract0.462256
early-stage oropharyngeal cancer0.392101
Otolaryngol Head Neck0.404239
index oropharyngeal cancers0.372661
-positive oropharyngeal cancers0.363257
neck retinoid chemoprevention0.355793
Abstract0.60039
Clin Oncol0.357598
Oncol Biol Phys0.772447
squamous cell carcinomas0.385763
primary tumor0.372966
field cancerization0.370643
neck cancer0.957961
neck tumors0.340144
oropharyngeal cancer0.807108
oropharyngeal SCC0.391565
oropharyngeal cancer incidence0.417437
CLICK HERE
1534 National Cancer Institute Html en Cartilage (Bovine and Shark) (PDQ®)–Health Professional Version Expert-reviewed information summary about the use of bovine and shark cartilage as a treatment for people with cancer. Note: The information in this summary is no longer being updated and is provided for reference purposes only.
angiogenesis inhibitor0.605921
cartilage factor0.525431
cartilage research0.52625
cartilage powder0.542054
cartilage treatment0.554222
shark cartilage0.973124
shark cartilage extracts0.55218
Biol Response Mod0.51035
cartilage cells0.557954
new blood vessels0.487052
tumor angiogenesis0.46716
dry shark cartilage0.564932
bovine cartilage0.627952
patients0.494925
Natl Cancer Inst0.505572
vascular endothelial growth0.488146
novel shark cartilage0.566963
bovine cartilage extract0.544409
bovine cartilage extracts0.534781
shark cartilage extract0.575893
powdered shark cartilage0.660454
metastatic renal cell0.492793
Japanese shark cartilage0.557325
new endothelial cells0.468808
shark cartilage products0.552328
endothelial cells0.499823
cartilage products0.616806
Oral shark cartilage0.568829
angiogenesis inhibitors0.486536
PUBMED Abstract0.506075
epiphyseal cartilage0.523025
cartilage tissue0.520334
endothelial cell proliferation0.510942
bovine cartilage preparations0.556431
human cartilage0.516475
shark cartilage-derived angiogenesis0.484691
Catrix treatment0.468204
shark cartilage product0.595815
cartilage therapy0.532177
Abstract0.525209
endothelial cell0.516176
renal cell carcinoma0.554811
phase i/ii trial0.471371
cartilage-derived collagenase inhibitor0.469151
tumor0.475092
shark cartilage inhibitor0.566866
cancer0.518101
bovine cartilage therapies0.544621
CLICK HERE
1562 National Cancer Institute Html en Hypopharyngeal Cancer Treatment (PDQ®)–Patient Version Expert-reviewed information summary about the treatment of hypopharyngeal cancer.
cancer treatment0.321266
high-dose radiation therapy0.323579
centimeters0.269921
cancer spreads0.270417
malignant tumor cells0.281954
body0.305644
chemotherapy0.290118
PDQ cancer information0.346817
stage III hypopharyngeal0.274417
clinical trial search0.347149
clinical trials0.698171
hypopharynx0.280224
cancer information summary0.319294
metastatic hypopharyngeal cancer0.310093
clinical trial0.551798
Recurrent hypopharyngeal cancer0.306668
patients0.317052
stage IV hypopharyngeal0.274937
nearby soft tissue0.271159
treatment clinical trial0.275593
NCI PDQ cancer0.283768
radiation therapy0.705932
Treatment Editorial Board0.281401
General information0.289657
hypopharyngeal cancer0.722179
general cancer information0.275426
treatment0.442202
new cancer treatments0.272872
NCI-supported cancer0.296123
cancer cells0.361641
Cancer Information Service0.276024
patient0.26688
lymph nodes0.350794
treatment clinical trials0.300384
National Cancer Institute0.364736
swollen lymph nodes0.277694
new treatment0.302418
External radiation therapy0.314938
neck0.309398
cancer research process0.269057
cancer clinical trials0.358746
stage0.310003
neck cancer0.286172
lymph node0.322344
cancer information summaries0.27414
comprehensive cancer information0.274558
cancer0.901171
standard treatment0.274055
Hypopharyngeal Cancer Treatment0.314822
CLICK HERE
1664 National Cancer Institute Html en Childhood Central Nervous System Atypical Teratoid/Rhabdoid Tumor Treatment (PDQ®)–Patient Version Expert-reviewed information summary about the treatment of childhood atypical teratoid/rhabdoid tumors
cancer treatment0.542006
metastatic brain tumors0.391418
ongoing clinical trials0.389415
PDQ cancer information0.511527
tumor suppressor genes0.452709
clinical trial search0.399694
brain tumors0.444671
CNS atypical teratoid/rhabdoid0.388691
clinical trials0.847224
Pediatric Treatment Editorial0.416481
Teratoid/Rhabdoid Tumor Treatment0.445097
cancer information summary0.463674
clinical trial0.521041
cancer cells0.510172
stem cell transplant0.396934
patients0.411179
primary brain tumors0.3918
treatment clinical trial0.409064
NCI PDQ cancer0.42324
radiation therapy0.555658
Treatment Editorial Board0.420841
Cord Tumors Treatment0.414346
late effects0.393798
treatment0.689522
new cancer treatments0.395428
PDQ treatment summary0.447943
childhood brain0.385451
Cancer Information Service0.399251
specific cancer cells0.397642
PDQ Pediatric Treatment0.40786
treatment clinical trials0.444124
National Cancer Institute0.458723
spinal cord0.616147
tumor cells0.437516
effects cancer treatment0.421518
new treatment0.427513
childhood cancer information0.400212
External radiation therapy0.395094
brain tumor0.405279
brain0.467984
atypical teratoid/rhabdoid tumor0.982554
PDQ summary0.439127
cancer clinical trials0.434177
cancer information summaries0.39809
comprehensive cancer information0.397631
cancer0.740574
appropriate cancer treatment0.419383
standard treatment0.391688
fast-growing tumor0.388774
CLICK HERE
1868 National Cancer Institute Html es Tratamiento del linfoma de Hodgkin infantil (PDQ®)–Versión para profesionales de salud Resumen de información revisada por expertos acerca del tratamiento del linfoma de Hodgkin infantil.
lymphocyte predominant hodgkin0.379318
Cancer Statistics Review0.310924
patients with hodgkin0.340461
Epstein-Barr virus with0.308343
lymphocyte predominance hodgkin0.361894
Pediatric Lymphocyte-Predominant Hodgkin0.335497
with nodular lymphocyte0.31309
Epstein-Barr virus0.324897
localized childhood hodgkin0.334572
familial classical hodgkin0.33579
células reed-sternberg0.313182
Radiat Oncol Biol0.310379
oncology group study0.317944
adolescent hodgkin0.33572
Children's Oncology Group0.329911
Estados Unidos0.310464
siguientes características0.32336
Leuk Lymphoma0.318529
hodgkin's lymphoma0.723879
childhood hodgkin0.361352
SEER Cancer Statistics0.312001
classic hodgkin0.335243
pediatric hodgkin0.427701
IV Hodgkin0.334995
adultos jóvenes0.32544
estadio iv0.319107
nodular lymphocyte-predominant hodgkin0.387944
nodular sclerosing hodgkin0.337374
high-risk hodgkin0.334348
pediatric patients with0.317448
with hodgkin0.425646
linfadenopatía periférica0.308361
non-Hodgkin's lymphoma0.3114
advanced hodgkin0.335086
National Cancer Institute0.316464
report from0.308961
with classical hodgkin0.37144
Hodgkin's lymphoma after0.346052
Epstein-Barr virus infection0.309022
células reed-sternberg llamadas0.308458
Pediatr Hematol Oncol0.310971
Lymphoma project0.310216
Clin Oncol0.390721
Hodgkin Lymphoma Group0.341816
Oncol Biol Phys0.310469
hodgkin lymphoma0.986519
lymphocyte-predominant hodgkin lymphoma0.45063
Cancer Institute0.316934
classical hodgkin lymphoma0.529436
CLICK HERE
1883 National Cancer Institute Html es Tratamiento de los tumores extracraneales de células germinativas en la niñez (PDQ®)–Versión para profesionales de salud Resumen de información revisada por expertos acerca del tratamiento de los tumores extracraneales de células germinativas en la niñez.
cell tumor protocols0.408279
germinativas malignas localización0.405353
células germinativas seminomatosos.Seminoma0.410393
cell tumor combined0.407867
germ cell tumours0.412186
Perlman EJ0.405253
Calaminus G0.412513
Cell Cancer Collaborative0.406794
cell tumors from0.406747
Göbel U0.406021
Cancer Group0.42074
cell tumor studies0.407558
pediatric oncology0.41388
células germinativas mixtos0.417539
International Germ Cell0.417008
Children's Oncology Group0.409014
mediastinal germ0.406328
cell tumor study0.408368
<2 cm0.405406
Metástasis peritoneales macroscópicas0.405941
germ cell neoplasms0.406391
Children's Cancer0.42175
cell tumors show0.406094
pediatric germ0.426106
adultos jóvenes0.40725
estadio iv0.405826
ganglios linfáticos ≥20.411723
Germ Cell Consensus0.412507
Cushing B0.405386
teratomas benignos0.407141
Genes Chromosomes Cancer0.438953
with germ0.406335
malignant germ cell0.462527
PDQ Tratamiento0.405882
childhood germ0.409831
cell tumors based0.405903
Clin Oncol0.444548
saco vitelino0.435575
linfáticos ≥2 cm0.408554
Schneider DT0.409517
Children's Cancer Group0.419331
Cell Consensus Classification0.409901
germ cell tumors0.974328
Kingdom Children Cancer0.408316
germ cell cancer0.410294
Children's Cancer Study0.409136
pediatric oncology group0.410202
oncology group0.420408
Cancer Study Group0.411644
CLICK HERE
2000 National Cancer Institute Html es Tratamiento de la histiocitosis de células de Langerhans (PDQ®)–Versión para pacientes Resumen de información revisada por expertos acerca del tratamiento de la histiocitosis de células de Langerhans.
cuánto aire0.415134
siguientes procedimientos0.528715
células madre0.858073
adultos jóvenes0.464664
efectos secundarios meses0.439126
siguientes aspectos0.434701
faja ajustadora0.428231
HCL infantil multisistémica0.546722
cuántos sistemas0.518567
genes ras0.453948
pequeña cantidad0.423844
células normales.ampliar exploración0.532323
vía oral0.42013
rayos x0.425227
gen braf0.666188
largo plazo0.44968
cuántas células0.518957
niño ayuda0.426203
efectos tardíos0.516221
escáner.ampliar exploración0.429231
tarde.ampliar ecografía0.427113
vías respiratorias0.424871
causa problemas0.424997
lesiones óseas0.423193
National Cancer Institute0.417904
IRMN).Ampliar Imágenes0.421648
siguientes riesgos0.415861
radiación uvb0.414555
Instituto Nacional0.431398
PDQ Tratamiento0.451873
antecedentes familiares0.589915
llamada genes ras0.432872
explorador tep0.430081
terapia fotodinámica causa0.453098
sistema nervioso central0.604707
Physician Data Query0.464236
mayores probabilidades0.416225
HCL multisistémica0.966875
terapia fotodinámica llamada0.451949
radiación ultravioleta0.561342
siguientes pruebas0.489919
CLICK HERE
3432 National Cancer Institute Html es Formaldehído y el riesgo de cáncer Hoja informativa que trata sobre el formaldehído y su posible relación con el cáncer. Incluye recursos para consultar mayor información.
leucemia mieloide0.978153
malignancies among workers0.549063
TW Alexander Drive0.542382
exterior-grade” pressed-wood0.527538
cancers among workers0.548254
Programa Nacional0.567373
largo plazo0.580439
Protección Ambiental0.673926
Salud Ocupacional0.583378
Mortality from0.576068
Instituto Nacional0.645898
Indoor Air0.527731
pequeñas cantidades0.52948
Lubin JH0.573228
posibles efectos0.584035
Estados Unidos0.527658
PubMed Abstract0.744149
Cancer Institute Cohort0.547453
East West Highway0.542743
International Agency0.53583
Environmental Protection Agency0.819165
probable carcinógeno0.619447
Product Safety Commission0.830336
among workers0.572581
New Hampshire Avenue0.541693
aislamiento uffi0.536299
National Toxicology Program0.804784
Drug Administration0.579636
Environmental Health Sciences0.548429
Occupational Environmental Medicine0.553867
Mortality among0.531703
Occupational Safety0.816569
materiales aislantes0.528932
British chemical workers0.549313
Emergency Management Agency0.637566
vías respiratorias0.526175
National Cancer Institute0.733699
National Institute0.579158
aislamiento tipo uffi0.553887
Health Administration0.662185
Consumer Product Safety0.833221
Indoor Environments Division0.548156
corto plazo0.574665
garment workers0.530046
Blair A0.564637
cabo estudios0.530631
12.º informe0.526826
Federal Emergency Management0.627002
Institutos Nacionales0.577211
CLICK HERE
15640 National Cancer Institute Html null Research & Development (R&D) Contracts null
CLICK HERE

 

 

 

Terms of Use | Privacy Policy
©2017 ARCHES Technology. All Rights Reserved.